ArticleTranslational oncology2024

First in human intraarterial delivery of tislelizumab for the treatment of pMMR locally advanced rectal cancer: A single-arm, open label, phase II clinical trial.

Weina Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.